These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24835677)

  • 41. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone.
    Li JG; Chen C; Yin J; Rice K; Zhang Y; Matecka D; de Riel JK; DesJarlais RL; Liu-Chen LY
    Life Sci; 1999; 65(2):175-85. PubMed ID: 10416823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of the mu-delta opioid receptor heteromer.
    O'Dowd BF; Ji X; O'Dowd PB; Nguyen T; George SR
    Biochem Biophys Res Commun; 2012 Jun; 422(4):556-60. PubMed ID: 22583900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and spectroscopic characterization of a large fragment of the mu-opioid receptor.
    Kerman A; Ananthanarayanan VS
    Biochim Biophys Acta; 2005 Feb; 1747(1):133-40. PubMed ID: 15680247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
    Xue JC; Chen C; Zhu J; Kunapuli S; DeRiel JK; Yu L; Liu-Chen LY
    J Biol Chem; 1994 Dec; 269(48):30195-9. PubMed ID: 7982926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors.
    Beigi F; Wainer IW
    Anal Chem; 2003 Sep; 75(17):4480-5. PubMed ID: 14632053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor.
    Chen C; Xue JC; Zhu J; Chen YW; Kunapuli S; Kim de Riel J; Yu L; Liu-Chen LY
    J Biol Chem; 1995 Jul; 270(30):17866-70. PubMed ID: 7629089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the mu opioid receptor involves conformational rearrangements of multiple transmembrane domains.
    Xu W; Sanz A; Pardo L; Liu-Chen LY
    Biochemistry; 2008 Oct; 47(40):10576-86. PubMed ID: 18778083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.
    Fukuda K; Terasako K; Kato S; Mori K
    FEBS Lett; 1995 Oct; 373(2):177-81. PubMed ID: 7589460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition.
    Befort K; Tabbara L; Kling D; Maigret B; Kieffer BL
    J Biol Chem; 1996 Apr; 271(17):10161-8. PubMed ID: 8626577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
    Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
    Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DAMGO recognizes four residues in the third extracellular loop to discriminate between mu- and kappa-opioid receptors.
    Seki T; Minami M; Nakagawa T; Ienaga Y; Morisada A; Satoh M
    Eur J Pharmacol; 1998 Jun; 350(2-3):301-10. PubMed ID: 9696421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioligand Binding Assay for an Exon 11-Associated Mu Opioid Receptor Target.
    Marrone GF; Majumdar S; Pasternak GW
    Methods Mol Biol; 2015; 1335():241-9. PubMed ID: 26260605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
    Doyle GA; Sheng XR; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
    Gene; 2007 Jun; 395(1-2):98-107. PubMed ID: 17398041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The three complementarity-determining region-like loops in the second extracellular domain of human Fc alpha/mu receptor contribute to its binding of IgA and IgM.
    Yang X; Zhao Q; Zhu L; Zhang W
    Immunobiology; 2013 May; 218(5):798-809. PubMed ID: 23182711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors.
    Strahs D; Weinstein H
    Protein Eng; 1997 Sep; 10(9):1019-38. PubMed ID: 9464566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity.
    Borics A; Tóth G
    J Mol Graph Model; 2010 Feb; 28(6):495-505. PubMed ID: 20036591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene.
    Cadet P; Mantione KJ; Stefano GB
    J Immunol; 2003 May; 170(10):5118-23. PubMed ID: 12734358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
    Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.